Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.3.23 (
GAS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The induction of
CD86
expression by IFN-gamma on the surface of various antigen presenting cells has been previously reported. In order to understand the mechanisms by which the expression of the
CD86
gene is regulated by IFN-gamma at the transcriptional level, we have cloned and characterized the 5'-flanking region of the human
CD86
gene. To functionally analyze the upstream regulatory region of the
CD86
gene, a series of luciferase reporter gene constructs were prepared and used for transfection of cells from the monocytic line U937 and Raji B cell line. Under basal conditions, functional activity of these constructs was detected in Raji cells, which show high constitutive expression of the
CD86 molecule
, but not in U937 cells, which show low expression of
CD86
in non-activated state. Induction of
CD86
expression by stimulation of U937 cells with IFN-gamma revealed the presence of two functional
GAS
(gamma-interferon activation site) elements. Gel mobility shift assays showed that these two
GAS
elements specifically bind an IFN-gamma-induced transcriptional complex. The DNA-protein complex was supershifted by antibody to Stat1 alpha (signal transducer and activator of transcription), but not by antibodies to Stat 2, Stat 3 and Sp1, indicating that
GAS
elements interact with Stat1 alpha. Point mutations in the
GAS
elements prevented the formation of DNA-protein complex and significantly reduced the responsiveness of the reporter gene to IFN-gamma. These findings suggest that two functional
GAS
elements within the human
CD86
promoter play an important role in the induction of
CD86
gene by binding to IFN-gamma-induced Stat1 alpha.
...
PMID:Cloning and functional characterization of the 5'-regulatory region of the human CD86 gene. 1077 51